Superbugs thrive as access to antibiotics fails in India
It's a grim paradox, doctors say.On the one hand, antibiotics are being overused until they no longer work, driving resistance and fuelling the rise of deadly superbugs. On the other hand, people are dying because they can't access these life-saving drugs.A new study by the non-profit Global Antibiotic Research and Development Partnership (GARDP) looked at access to antibiotics for nearly 1.5 million cases of carbapenem-resistant Gram-negative (CRGN) infections across eight major low- and middle-income countries, including India, Brazil and South Africa. CRGN bacteria are superbugs resistant to last-line antibiotics - yet only 6.9% of patients received appropriate treatment in the countries studied.India bore the lion's share of CRGN infections and treatment efforts, procuring 80% of the full courses of studied antibiotics but managing to treat only 7.8% of its estimated cases, the study in The Lancet Infectious Diseases journal reports. (A full drug course of antibiotics refers to the complete set of doses that a patient needs to take over a specific period to fully treat an infection.) Common in water, food, the environment and the human gut, Gram-negative bacteria cause infections such as urinary tract infections (UTIs), pneumonia and food poisoning. They can pose a serious threat to newborns and the elderly alike. Especially vulnerable are hospital patients with weakened immunity, often spreading rapidly in ICUs and proving difficult - and sometimes impossible - to treat. Treating carbapenem-resistant Gram-negative bacterial infections is doubly difficult because those bacteria are resistant to some of the most powerful antibiotics."These infections are a daily reality across all age groups," says Dr Abdul Gaffar, infectious disease consultant at Apollo Hospital in India's Chennai city. "We often see patients for whom no antibiotic works - and they die."The irony is cruel. While the world tries to curb antibiotic overuse, a parallel tragedy plays out quietly in poorer nations: people dying from treatable infections because the right drugs are out of reach.
"For years, the dominant narrative has been that antibiotics are being overused, but the stark reality is that many people with highly drug-resistant infections in low- and middle-income countries are not getting access to the antibiotics they need," says Dr Jennifer Cohn, GARDP's Global Access Director and senior author of the study.India's 'blockbuster' drugs to take on deadly superbugsIndia facing a pandemic of antibiotics-resistant superbugsThe study examined eight intravenous drugs active against carbapenem-resistant bacteria - ranging from older antibiotics including Colistin to newer ones such as Ceftazidime-avibactam. Of the few available drugs, Tigecycline was the most widely used. Researchers blame the treatment gap on weak health systems and limited access to effective antibiotics. For example, only 103,647 full treatment courses were procured of Tigecycline across eight countries - far short of the 1.5 million patients who needed them, the study found. This highlighted a major shortfall in the global response to drug-resistant infections. What prevents patients with drug-resistant infections in India from getting the right antibiotics? Physicians point to multiple barriers - reaching the right health facility, getting accurate diagnostic tests, and accessing effective drugs. Cost remains a major hurdle, with many of these antibiotics priced far beyond the reach of poorer patients.
"Those who can afford these antibiotics often overuse them; those who can't, don't get them at all," says Dr Gaffar. "We need a system that ensures access for the poor and prevents misuse by the well-to-do."To improve access, these drugs must be made more affordable. To prevent misuse, stronger regulation is key. "Ideally, every antibiotic prescription in hospitals should require a second sign-off - by an infection specialist or microbiologist," says Dr Gaffar. "Some hospitals do this, but most don't. With the right oversight, regulators can ensure this becomes standard practice."To fix the access problem and curb misuse, both smarter policies and stronger safeguards are essential, say researchers. But access alone won't solve the crisis - the pipeline of new antibiotics is drying up. The decline in antibiotic R&D - and the limited availability of existing drugs - is a global issue.India bears one of the world's heaviest burdens of antimicrobial resistance (AMR), but it may also hold the key to combating it - both at home and globally, researchers say."India is also one of the largest markets for new antibiotics and can successfully advocate for the development and access of new antibiotics," says Dr Cohn. With a strong pharmaceutical base, the country is emerging as a hub for AMR innovation, from promising new antibiotics to advanced diagnostics.Dr Cohn says India can strengthen its antibiotic response by generating local data to better estimate needs and pinpoint gaps in the care pathway. This would allow for more targeted interventions to improve access to the right drugs. Innovative models are already emerging - Kerala state, for instance, is using a "hub-and-spoke approach" to support lower-level facilities in managing serious infections. Coordinated or pooled procurement across hospitals or states could also reduce the cost of newer antibiotics, as seen with cancer drug programs, researchers say.Without access to the right antibiotics, modern medicine begins to unravel - doctors risk losing the ability to safely perform surgery, treat complications in cancer patients, or manage everyday infections. "As an infectious disease doctor, I see appropriate use as one part - but only one part - of access," says Dr Gaffar. "When we get new antibiotics, it's important to save them on one hand - and save them for right patients." Clearly, the challenge is not just to use antibiotics wisely, but to ensure they reach those who need them most.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
an hour ago
- The Guardian
Wes Streeting announces investigation into NHS maternity services
The health secretary, Wes Streeting, has announced the launch of a national investigation into NHS maternity services. The new rapid investigation is intended to provide truth to families suffering harm, as well as driving urgent improvements to care and safety. It comes after Streeting met families who had lost babies and amid the ongoing investigations at some NHS trusts into poor maternity care. In a statement, the health secretary said: 'For the past year, I have been meeting bereaved families from across the country who have lost babies or suffered serious harm during what should have been the most joyful time in their lives. 'What they have experienced is devastating – deeply painful stories of trauma, loss, and a lack of basic compassion – caused by failures in NHS maternity care that should never have happened. Their bravery in speaking out has made it clear: we must act – and we must act now. 'I know nobody wants better for women and babies than the thousands of NHS midwives, obstetricians, maternity and neonatal staff, and that the vast majority of births are safe and without incident, but it's clear something is going wrong. 'That's why I've ordered a rapid national investigation to make sure these families get the truth and the accountability they deserve, and ensure no parent or baby is ever let down again. I want staff to come with us on this, to improve things for everyone. 'We're also taking immediate steps to hold failing services to account and give staff the tools they need to deliver the kind, safe, respectful care every family deserves. 'Maternity care should be the litmus test by which this government is judged on patient safety, and I will do everything in my power to ensure no family has to suffer like this again.'
The Independent
2 hours ago
- The Independent
British holidaymaker in critical condition after catching Legionnaires' disease in Crete
A British tourist is in intensive care after catching a serious lung disease while on holiday in Greece. Donna Jobling from Hull was on an all-inclusive holiday on the Greek island of Crete when she fell ill on 6 June. Her condition continued to worsen over the next two days and she was admitted to hospital in Heraklion. The 57-year-old had caught Legionnaires ' disease, a lung infection you can get after inhaling droplets of water from things like air conditioning or hot tubs. A doctor told Ms Jobling's husband, Sid, that her lungs were quickly shutting down, then she was put into an induced coma. She and her husband had been travelling with easyJet holidays. "We're so sorry to hear that Ms Jobling is unwell, and we're continuing to support her and her family in every way we can," a spokesperson for the holiday provider said. While it is not confirmed that the hotel is the source of the infection, as a precaution customers were moved out and have been provided alternative hotel accommodation. Those planning to stay in the hotel over the next four weeks have also been given alternative options. As well as moving other customers out of the hotel, easyJet Holidays said it has been in touch with customers who have recently returned home from the hotel. "Our customers' safety and wellbeing is our top priority, and we'll continue to do all we can to support them,' the spokesperson said. The hotel where Ms Jobling fell ill is currently working with local health authorities on the island. 'Donna has an abundance of loving family and friends who just want to get the chance to go over there to support her and Sid, who is currently there alone and has been for two weeks,' a GoFundMe fundraising page for Ms Jobling says. The fundraiser, organised by Ms Jobling's niece, has raised £510 out of an £1,200 target as of Monday morning. It added: 'We really don't know what the outcomes can be at this point, with very little good news from doctors. Anything will help at this hard time; we just need people there to support them.' Ms Jobling has been in the intensive care unit in critical condition since 11 June. The UK's Foreign, Commonwealth & Development Office said it is supporting the family and is in contact with the local authorities. After Ms Jobling was hospitalised, the Greek health ministry issued a statement to hoteliers in Crete to "raise awareness among all those involved in monitoring the quality of water for human consumption especially with regard to Legionella". The disease is uncommon, but it can be very serious. It is unclear what caused the infection, but you can usually contract the illness by inhaling tiny droplets of water containing bacteria. The disease tends to be caught in places like hotels, as well as hospitals and offices, where bacteria have got into the water supply. Symptoms include coughing, shortness of breath, chest pain or discomfort, a high temperature and flu-like symptoms. An emergency alert has also been issued on the island by the European Centre for Disease Prevention and Control following the diagnosis.
The Independent
2 hours ago
- The Independent
Trump says he should get Nobel Peace Prize - hours before US bombs Iran
Donald Trump reignited his claim for the Nobel Peace Prize, asserting his pivotal role in resolving various global conflicts. Hours before the US bombed nuclear sites in Iran's Furdow, a reporter questioned the US President about a suggestion from Matt Gaetz regarding peace efforts between Israel and Iran. Mr Trump highlighted his involvement in the India - Pakistan conflict, saying, 'I mean the big one is India and Pakistan. You could, I should have gotten it four or five times.' While Pakistan has publicly thanked Trump for his intervention in the ceasefire, India has consistently maintained its stance, affirming it would 'never accept third-party negotiation.'
